CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- 4 Grant or award Director acquired 18,328 shares (grant or award)
- 4 Grant or award Director acquired 18,328 shares (grant or award)
- 4 Grant or award Director acquired 18,328 shares (grant or award)
- 4 Grant or award Director acquired 18,328 shares (grant or award)
- 4 Shares withheld for taxes Sr. VP & Chief Scientific Off. gave up 6,486 shares (to pay taxes)
- 4 Shares withheld for taxes Sr. VP & Chief Comm. Officer gave up 5,376 shares (to pay taxes)
- 4 Shares withheld for taxes President & Chief Exec Officer gave up 18,659 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and CFO gave up 5,457 shares (to pay taxes)
- 4 Grant or award Sr VP & Chief Business Officer acquired 67,126 shares (grant or award)
- 4 Grant or award President & Chief Exec Officer acquired 289,334 shares (grant or award)
- 4 Grant or award Sr. VP & Chief Comm. Officer acquired 92,587 shares (grant or award)
- 4 Grant or award SVP and CFO acquired 115,734 shares (grant or award)
- 4 Grant or award Sr. VP & Chief Scientific Off. acquired 92,587 shares (grant or award)
- 4 Shares withheld for taxes SVP and CFO gave up 7,940 shares (to pay taxes)
- 4 Open-market buy 10% owner bought 245,828 shares at $3,485,841.04 ($856,917,331,181)
- 4 Grant or award Sr VP & Chief Business Officer acquired 105,288 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes President & CEO gave up 24,698 shares (to pay taxes)
- 4 Open-market sale Director sold 2,438 shares at $16.85 ($41,080)
- 4 Open-market sale Director sold 16,313 shares at $16.32 ($266,228)
Page 13 of 39 · 776 filings